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Impaired of a non-DNA dependent methylation status decides the fat decision of bone 
marrow-derived C3H10T1/2 stem cell 
ABSTRACT 
A decrease in the lineage commitment of multipotent Mesenchymal stem cells (MSC) to the 
bone forming osteoblast lineage and an increase in the commitment to the fat forming 
adipocyte lineage is more common in bone marrow of elderly persons. A link between 
methylation status and MSC differentiation remains unclear. Therefore, we hypothesize that 
hypomethylation may decide the fate decisions of MSC. In the current study, murine bone 
marrow derived-C3H10T1/2 stem cell was used to examine the role of methylation 
mechanism on the differentiation potential of stem cells into osteoblasts or adipocytes. 
C3H10T1/2 cells were treated with Periodate oxidized adenosine (Adox), an inhibitor of S-
adenosylhomocysteine-dependent hydrolase (SAHH), which in turn block the non-DNA 
methylation pathway. The effect of hypomethylation on C3H10T1/2 stem cell differentiation 
was determined by measuring the alkaline phosphates activity and the degree of 
mineralization as well as Oil-red O staining and lipid content. The ratio of S-
adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) was determined as a 
metabolic indicator of cellular methylation potential. It was clearly observed that 
hypomethylation significantly (P < 0.05) reduces SAM: SAH ratio, alkaline phosphates 
activity, calcification and thereby, osteoblast differentiation. Conversely, adipocyte 
differentiation was stimulated by hypomethylation. Altogether, our data suggest that non-
DNA hypomethylation changes the differentiation potential of C3H10T1/2 stem cells for less 
osteogenic and more adipogenic. 
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